Comparison of the GeneFinder TM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection?
The study was to assess the diagnostic performance of the GeneFinderTMCOVID-19 Plus RealAmp Kit on the ELITe InGenius sample-to-result platform. Of 128 randomly selected patients, 58 (45%) tested positive and 55 (43%) tested negative in both platforms. The sensitivity of the In Genius platform was 100% (95% confidence interval 94-100).
